Navigation Links
Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting
Date:6/17/2011

MOUNTAIN VIEW, Calif., June 17, 2011 /PRNewswire/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the positive results from REVIVE-RP (TA-303), a phase 3 clinical trial evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED),will be presented this afternoon at the 2011 Cancer Survivorship and Sexual Health Symposium in Washington D.C.  The meeting is jointly sponsored by the International Society for Sexual Medicine (ISSM) and the Sexual Medicine Society of North America (SMSNA).  John Mulhall, M.D., Director of the Male Sexual & Reproductive Medicine Program at the Memorial Sloan Kettering Cancer Center in New York, will present the results during the peer-reviewed, moderated poster session.  

Avanafil met all primary endpoints by demonstrating improvements from baseline in erectile function as measured by the Sexual Encounter Profile (both SEP 2 and SEP 3) and improvement in the erectile function domain of International Index of Erectile Function (IIEF).  The study also indicated a favorable safety profile and successful intercourse (as measured by SEP 3) was observed as early as 15 minutes after dosing, without any restrictions on food or alcohol.

"Patients who have undergone a radical prostatectomy (RP) often have severe erectile dysfunction.  Despite advancements in surgery, it can take several months or years to normalize erections.  RP patients are difficult to treat but the positive results of avanafil in these patients suggest that, if approved, avanafil could be an attractive treatment option for these patients," commented Dr. Mulhall.  "I am pleased to be presenting these positive results with the health professionals attending the Cancer Survivorship Meeting.  The safety and efficacy demonstrated in this trial may offer hope to patients who
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Neurelis Announces Positive Results from Phase 1 Pharmacokinetic Study of NRL-01 (intranasal diazepam)
2. Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil
3. BioSpecifics Announces Positive XIAPEX® Data Presented at XVI Annual Federation of European Societies for Surgery of the Hand Congress
4. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
5. Boehringer Ingelheim to present new data at ASCO annual meeting regarding its investigational compound afatinib in EGFR-mutation positive patients with advanced NSCLC
6. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
7. KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain
8. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
9. Positive Results from Long-Term Phase 3 Study of Avanafil Featured at American Urological Association Annual Meeting
10. Positive Results Reported for Phase II Randomized Double-Blind Clinical Trial for the Treatment of Drug-Resistant Epilepsy Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Reportlinker Adds Advanced Lung Cancer with EGFR Mutation Positive Adenocarcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)...  Akron Children,s Hospital has been designated a Diagnostic ... of Radiology (ACR), making it the first hospital in ... hospital in the United States ... from the ACR as a DICOE provides validation that ... with national benchmarks," says Dr. Michael Rubin , ...
(Date:3/2/2015)... Ohio , March 2, 2015  Sarnova, ... the launch of the new www.tri-anim.com ... full-service, specialty healthcare distributor of respiratory, anesthesia and ... country. The site has many ... overall experience, making online shopping and ordering easier ...
(Date:3/2/2015)... DIEGO , March 2, 2015  Tandem Diabetes ... device company and manufacturer of the t:slim® and t:flex™ ... previously announced public offering of common stock have exercised ... its common stock at a price to the public ... from the offering is expected to be $64.8 million, ...
Breaking Medicine Technology:Akron Children's designated ACR Diagnostic Imaging Center of Excellence 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 2Tri-anim Health Services Launches New Website Featuring Improved Product Selection and Ease of Ordering 3Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 2Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Underwritten Public Offering of Common Stock 3
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... After a rigorous evaluation process that ... and long-term strategy, Blood Centers of America (BCA) has ... member centers’ testing needs. , BCA, which comprises more ... 30 percent of the U.S. blood supply, made the ... committed to drive cost savings to members,” said Bill ...
(Date:3/2/2015)... 2015 New York singer/songwriter Richie ... delivering a plenary address entitled Finding the Music ... of Healing and Recovery at this year’s National ... Executive Summit (BHES).     , With more than 300 ... been recorded by some of the biggest names ...
(Date:3/2/2015)... 2015 Over the last five years ... vendors seeking to expand their geographic presence and achieve ... to reach $6.2 billion by 2019 at CAGR of ... the U.S. and Canada and a major part of ... regions such as Asia-Pacific including China and India, Latin ...
Breaking Medicine News(10 mins):Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 2Health News:Blood Centers of America Chooses QualTex Laboratories as Vendor of Choice 3Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 2Health News:Therapeutic Ultrasound Devices Market worth $6.2 Billion by 2019 - New Research Report by MarketsandMarkets 3
... researchers say , MONDAY, Oct. 19 (HealthDay News) -- ... nausea and vomiting as much if they take dextrose, ... the most common post-operative complications, [vomiting and nausea] remains ... following surgery," said Dr. Susan Dabu-Bondoc of Yale School ...
... say , MONDAY, Oct. 19 (HealthDay News) -- The ... (IBD) increases the risk of cancers related to viral ... Crohn,s disease and ulcerative colitis. Thiopurine drugs are used ... remission in IBD patients. , For this study, French ...
... The Board of Directors of the ... assistance organizations, is pleased to announce the appointment of ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090930/NY84016LOGO ) ... Directors of the HealthWell Foundation commented, "Mary is an ...
... N.J. Oct. 19 America,s Toughest Trainer and Health ... is designed specifically for on-the-go fitness! Majesco Entertainment Company ... games for the mass market, and Interactive Game Group, ... for Nintendo DS(TM) will be available at retailers ...
... Funding has brought together under a single domain ( ... tools organizations need for a complete end-to-end OPEB liability ... consultants and other service providers, Roundstone Healthcare Funding and ... liability estimation, dedicated Trust formation, strategic asset management services ...
... IPRO has been awarded special federal funding to ... As the Medicare Quality Improvement Organization (QIO) for the ... performance improvement in a variety of settings. QIOs operate ... with the federal Centers for Medicare & Medicaid Services ...
Cached Medicine News:Health News:Easy Way to Prevent Post-Op Nausea? 2Health News:Drugs for Inflammatory Bowel Might Increase Cancer Risk 2Health News:HealthWell Foundation(R) Appoints New Executive Director 2Health News:Majesco Entertainment and Interactive Game Group Release 'Jillian Michaels Fitness Ultimatum 2010' For Nintendo DS(TM) 2Health News:Majesco Entertainment and Interactive Game Group Release 'Jillian Michaels Fitness Ultimatum 2010' For Nintendo DS(TM) 3Health News:IPRO Wins Federal Contract to Support Hospice Oversight 2
For the quantitative in vitro determination of IgE in Human Serum or Plasma....
For the quantitative in vitro determination of IgG in serum and plasma. This product is suitable for use on the Aeroset...
Latex-enhanced immunoturbidimetric assay for the quantitative in vitro determination of C-reactive protein in serum and plasma...
Latex agglutination slide test for the qualitative and semi-quantitative in vitro determination of CRP in serum....
Medicine Products: